Evidence map›Paper›PMID 42359048›Full record

ArticleResearch (Washington, D.C.)2026

Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.

Ning Shi, Caiping Ren, Liang Zhang, Lei Wang, Xuechen Yang, Xiaobo Li, Yangyihua Zhou, Jie Wang, Pinnan Zhao, Chaoyan Yao and 10 more

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ning ShiDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Caiping RenDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Liang ZhangAcademy of Military Medical Sciences, Beijing 100850, China.
Lei WangDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Xuechen YangAcademy of Military Medical Sciences, Beijing 100850, China.
Xiaobo LiAcademy of Military Medical Sciences, Beijing 100850, China.
Yangyihua ZhouAcademy of Military Medical Sciences, Beijing 100850, China.
Jie WangAcademy of Military Medical Sciences, Beijing 100850, China.
Pinnan ZhaoAcademy of Military Medical Sciences, Beijing 100850, China.
Chaoyan YaoDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Yaowei MaAcademy of Military Medical Sciences, Beijing 100850, China.
Juan TianAcademy of Military Medical Sciences, Beijing 100850, China.
Qianping HuangDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Can XuAcademy of Military Medical Sciences, Beijing 100850, China.
Xiaonan KuangAcademy of Military Medical Sciences, Beijing 100850, China.
Weidong LiuDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Xingjun JiangDepartment of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Jun YeBeijing Key Laboratory of Key Technologies for Natural Drug Delivery and Novel Formulations, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xiang GaoAcademy of Military Medical Sciences, Beijing 100850, China.
Longlong LuoAcademy of Military Medical Sciences, Beijing 100850, China.ORCID https://orcid.org/0000-0002-8307-6478

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical utility of nanobodies in solid tumor therapy is constrained by a fundamental biophysical trade-off: rapid renal clearance necessitates half-life extension, which in turn demands ultrahigh affinity to prevent dissociation from the target under systemic washout conditions. While generative artificial intelligence has substantially advanced structure prediction, it often fails to resolve the subtle energetic frustrations at protein-protein interfaces required for affinity maturation. Here, we present a physics-informed artificial intelligence framework that integrates AlphaFold 3 structural priors with molecular dynamics simulations to rationally design a picomolar anti-carcinoembryonic antigen nanobody. By employing variable dielectric molecular mechanics/generalized Born surface area decomposition, we identified interfacial residues that were structurally permissible but thermodynamically suboptimal. We subsequently constructed a focused library to resolve these bottlenecks through electrostatic optimization, desolvation penalty minimization, and van der Waals packing refinement. This strategy achieved a 99% binding positivity rate and yielded variants with picomolar affinity (

Identifiers

PMID42359048
PMCPMC13291490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.